Addressing osteoporosis treatment after hemiarthroplasty for a femoral neck fracture: impact on survival rates after a subsequent periprosthetic femoral fracture - a multicenter (TRON group) retrospective study.
Bisphosphonate
Femoral neck fracture
Multicenter
Periprosthetic femoral fracture
Journal
Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988
Informations de publication
Date de publication:
20 09 2023
20 09 2023
Historique:
received:
04
03
2023
accepted:
08
09
2023
medline:
21
9
2023
pubmed:
20
9
2023
entrez:
19
9
2023
Statut:
epublish
Résumé
This study investigated the impact of osteoporosis treatment on the prognosis of patients with periprosthetic femoral fracture (PPF) following femoral neck fracture (FNF). Our results suggested an association between osteoporosis treatment and potentially improved survival prognosis in patients who underwent surgery for PPF. These results imply that osteoporosis treatment may have a beneficial effect on patient outcomes. This study aimed to investigate the effect of osteoporosis treatment on the prognosis of periprosthetic femoral fracture (PPF) patients after femoral neck fracture. A multicenter retrospective study named as TRON was conducted. The study population included 156 PPF patients who had undergone hemiarthroplasty for femoral neck fracture between January 2010 and December 2019. Patients were divided based on whether they had received osteoporosis treatment before PPF injury. A log-rank test was used to compare survival rates. We conducted a Cox proportional hazards analysis to identify factors associated with the survival rate after PFF injury. Twenty-seven of the 156 patients had received osteoporosis treatment prior to PPF injury. The 1-year and 2-year overall survival rates after PPF were 80.9% and 75.3%, respectively. The log-rank test revealed that the 1-year survival rate with and without osteoporosis treatment was 89.5% and 78.1%, respectively (P=0.012). In the Cox proportional hazards analysis, age, BMI, presence or absence of surgery, and presence or absence of osteoporosis treatment showed independent associations with the survival rate after PFF injury. The hazard ratio for the presence of osteoporosis treatment was 0.22 (95% confidence interval 0.07-0.75, P=0.015). The findings of this study suggest an association between osteoporosis treatment and potentially improved survival prognosis in patients who underwent surgery for PPF. These results imply that osteoporosis treatment may have a beneficial effect on patient outcomes. It is important to consider that osteoporosis treatment could be significant not only in preventing secondary fractures but also in potentially improving prognosis in the rare event of PPF.
Identifiants
pubmed: 37726555
doi: 10.1007/s11657-023-01330-x
pii: 10.1007/s11657-023-01330-x
doi:
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122Informations de copyright
© 2023. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.
Références
Sidler-Maier CC, Waddell JP (2015) Incidence and predisposing factors of periprosthetic proximal femoral fractures: a literature review. Int Orthop. https://doi.org/10.1007/s00264-015-2721-y
Marino DV, Mesko DR (2022) Periprosthetic proximal femur fractures. In: StatPearls. StatPearls Publishing, Florida. https://www.ncbi.nlm.nih.gov/books/NBK557559/ . Accessed 19 Feb 2023
Moreta J, Uriarte I, Bidea I, Foruria X, Legarreta MJ, Etxebarría-Foronda I (2021) High mortality rate following periprosthetic femoral fractures after total hip arthroplasty. A multicenter retrospective study. Injury. https://doi.org/10.1016/j.injury.2021.01.035
Kurokawa H, Takegami Y, Tokutake K, Takami H, Iwata M, Terasawa S, Inoue H, Imagama S (2023) Predictive factors for one-year mortality after surgery for periprosthetic femoral fracture: a retrospective multicenter (TRON group) study. J Orthop Sci. https://doi.org/10.1016/j.jos.2022.12.015
Takami H, Takegami Y, Tokutake K, Kurokawa H, Iwata M, Terasawa S, Oguchi T, Imagama S (2023) Mortality and clinical outcomes of Vancouver type B periprosthetic femoral fractures: a multicentre retrospective study. Bone Jt Open. https://doi.org/10.1302/2633-1462.41.BJO-2022-0145.R1
Park KJ, Menendez ME, Barnes CL (2017) Perioperative periprosthetic fractures associated with primary total hip arthroplasty. J Arthroplasty. https://doi.org/10.1016/j.arth.2016.08.034
Abdel MP, Cottino U, Mabry TM (2015) Management of periprosthetic femoral fractures following total hip arthroplasty: a review. Int Orthop. https://doi.org/10.1007/s00264-015-2979-0
Thien TM, Chatziagorou G, Garellick G, Furnes O, Havelin LI, Mäkelä K, Overgaard S, Pedersen A, Eskelinen A, Pulkkinen P, Kärrholm J (2014) Periprosthetic femoral fracture within two years after total hip replacement: analysis of 437,629 operations in the Nordic arthroplasty register association database. J Bone Joint Surg Am. https://doi.org/10.2106/JBJS.M.00643
Saito T, Sterbenz JM, Malay S, Zhong L, MacEachern MP, Chung KC (2017) Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis. Osteoporos Int. https://doi.org/10.1007/s00198-017-4175-0
Iida H, Sakai Y, Seki T, Watanabe T, Wakao N, Matsui H, Imagama S (2022) Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture. Osteoporos Int. https://doi.org/10.1007/s00198-021-06264-z
González-Quevedo D, Bautista-Enrique D, Pérez-Del-Río V, Bravo-Bardají M, García-de-Quevedo D, Tamimi I (2020) Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study. Osteoporos Int. https://doi.org/10.1007/s00198-019-05153-w
Mayhew D, Mendonca V, Murthy BVS (2019) A review of ASA physical status - historical perspectives and modern developments. Anaesthesia. https://doi.org/10.1111/anae.14569
Yamada Y, Takegami Y, Tokutake K, Taguchi K, Kuwahara Y, Komaki K, Imagama S (2022) Predictive factors for mortality after distal femoral fractures in the elderly: a retrospective multicenter (TRON group) study. Injury. https://doi.org/10.1016/j.injury.2022.01.002
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. https://doi.org/10.1016/0021-9681(87)90171-8
Sachdev M, Sun JL, Tsiatis AA, Nelson CL, Mark DB, Jollis JG (2004) The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2003.10.031
Duncan CP, Masri BA (1995) Fractures of the femur after hip replacement. Instr Course Lect 44:293–304
pubmed: 7797866
Parker MJ, Palmer CR (1993) A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg Br. https://doi.org/10.1302/0301-620X.75B5.8376443
Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. https://doi.org/10.1038/bmt.2012.244
Haughom BD, Basques BA, Hellman MD, Brown NM, Della Valle CJ, Levine BR (2018) Do mortality and complication rates differ between periprosthetic and native hip fractures? J Arthroplasty. https://doi.org/10.1016/j.arth.2018.01.046
Füchtmeier B, Galler M, Müller F (2015) Mid-term results of 121 periprosthetic femoral fractures: increased failure and mortality within but not after one postoperative year. J Arthroplasty. https://doi.org/10.1016/j.arth.2014.11.006
Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res. https://doi.org/10.1002/jbmr.2202
Kim SC, Kim MS, Sanfélix-Gimeno G, Song HJ, Liu J, Hurtado I, Peiró S, Lee J, Choi NK, Park BJ, Avorn J (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med. https://doi.org/10.1016/j.amjmed.2015.01.014
Taylor L, Kimata C, Siu AM, Andrews SN, Purohit P, Yamauchi M, Bratincsak A, Woo R, Nakasone CK, Lim SY (2021) Osteoporosis treatment rates after hip fracture 2011-2019 in Hawaii: undertreatment of men after hip fractures. Osteoporos Sarcopenia. https://doi.org/10.1016/j.afos.2021.08.002
Mahaisavariya C, Vanitcharoenkul E, Kitcharanant N, Chotiyarnwong P, Unnanuntana A (2023) Exploring the osteoporosis treatment gap after fragility hip fracture at a tertiary university medical center in Thailand. BMC Geriatr. https://doi.org/10.1186/s12877-023-03778-5
Märdian S, Perka C, Schaser KD, Gruner J, Scheel F, Schwabe P (2017) Cardiac disease and advanced age increase the mortality risk following surgery for periprosthetic femoral fractures. Bone Joint J. https://doi.org/10.1302/0301-620X.99B7.BJJ-2016-0974.R1
Bhattacharyya T, Chang D, Meigs JB, Estok DM 2nd, Malchau H (2007) Mortality after periprosthetic fracture of the femur. J Bone Joint Surg Am. https://doi.org/10.2106/JBJS.F.01538
Gausden EB, Wellman DS (2019) Biomechanics of periprosthetic fixation: plates, nails, cables, and allografts. J Orthop Trauma. https://doi.org/10.1097/BOT.0000000000001569
Weiser L, Korecki MA, Sellenschloh K, Fensky F, Püschel K, Morlock MM, Rueger JM, Lehmann W (2014) The role of inter-prosthetic distance, cortical thickness and bone mineral density in the development of inter-prosthetic fractures of the femur: a biomechanical cadaver study. Bone Joint J. https://doi.org/10.1302/0301-620X.96B10.33461
Lenz M, Lehmann W, Wähnert D (2016) Periprosthetic fracture fixation in osteoporotic bone. Injury. https://doi.org/10.1016/S0020-1383(16)47008-7
D'Silva KM, Cromer SJ, Yu EW, Fischer M, Kim SC (2021) Risk of incident atrial fibrillation with zoledronic acid versus denosumab: a propensity score-matched cohort study. J Bone Miner Res. https://doi.org/10.1002/jbmr.4174
Wu ST, Chen JF, Tsai CJ (2021) The impact of bisphosphonates on mortality and cardiovascular risk among osteoporosis patients after cardiovascular disease. J Formos Med Assoc. https://doi.org/10.1016/j.jfma.2020.12.014
Thosani N, Thosani SN, Kumar S, Nugent Z, Jimenez C, Singh H, Guha S (2013) Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis. J Clin Oncol. https://doi.org/10.1200/JCO.2012.42.9530